# Cell Harvesting Market

> Cell Harvesting Market Research Report: Size, Share, Trend Analysis By Product Type (Manual Cell Harvesters, Automated Cell Harvesters), By Applications (Biopharmaceutical Application, Stem Cell Research), End User (Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.79%
- **2024:** $ 6.29 Billion
- **2025:** $ 6.84 Billion
- **2035:** $ 15.89 Billion
- **Key Players:** Thermo Fisher Scientific (US), Merck KGaA (DE), BD (US), Lonza Group (CH), Miltenyi Biotec (DE), STEMCELL Technologies (CA), Corning Incorporated (US), F. Hoffmann-La Roche Ltd (CH)

**Report ID:** MRFR/LS/5337-HCR · **Pages:** 90 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/cell-harvesting-market-6801

---

## Market Summary

## **Global Cell Harvesting Market Overview**

Cell Harvesting Market Size was valued at USD 5.78 Billion in 2023. The Global Cell Harvesting industry is projected to grow from USD 5.89 Billion in 2024 to USD 10.34 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.9% during the forecast period (2024 - 2032).

Cell harvesting involves separating the cell culture from the growth media using procedures including centrifugation, microfiltration, and depth filtration.

Numerous reasons, including an increase in chronic illnesses and disorders, rapid expansions in the biotechnology and pharmaceutical sectors, and increased research in regenerative treatments, are projected to boost the cell harvesting industry. Furthermore, the cost-effectiveness, convenience of use, and durability of harvesters, as well as technical breakthroughs and design improvement of cell harvester devices, drive the cell harvesting market's growth. Several corporations are also launching new products to boost their market position.

**In December 2023**, Cheetah Prime- A PerkinElmer Inc. project- will be demonstrated, shaped as an automated closed system letting out a chance of the sterile separation of different types of cells. Fat cell grabber machine is an advanced technology that aims at increasing the number and viability of cells.

In November 2023 indicated that Argos Technologies Inc. had entered into an agreement with a leading European research institute to carry out clinical trials on their sophisticated fat cell grabber machine (fat cell harvester), which could increase both numbers and viability of obtained cells.In October 2023, Terumo Corporation bought Athersys, Inc., a firm involved in developing cellular therapy techniques, so as to get access to Athersys adipose-derived stem cell platform that might be integrated into Terumo’s cell harvesting devices.CliniMACS Prodigy platform was launched by Miltenyi Biotec in the month of October 2023 as it sported an automated workflow for isolating and enriching cells from various sources making it ideal for R&D-related cellular therapies.For instance, Orgenesis invested $50 million into Morgenesis after receiving FDA approval for its point-of-care autologous cell therapy product.As an illustration, researchers at the University of Technology Sydney (UTS) came up with this idea along with Regeneus biotech company in June 2022, printed on a 3D printer microfluidic stem-cell harvesting system.

In fact, it is a simple and cheap device that can trap stem cells escaping from bioreactor systems, facilitating cost-effective and scalable process control.In March 2022 Stem Cell Therapies (SCT) Mission allocated $150 million to novel therapies that are safe, effective and accessible, thereby enhancing better health outcomes involving the patients as well as carers—Australian Government Department of Health and Aged Care said. Thereby, this mission funds projects to develop new therapies that are safe and effective for patients, to develop the workforce capacity, as well as translate stem cell innovations into commercial products.

However, the technical complexity of harvesters, coupled with ethical issues related to embryonic stem cell research may curb the growth of the cell harvesting market. Stringent government regulations and mandatory licensing rules may also hamper the market growth during the assessment period.

## **Cell Harvesting Market Segment Insights**

The cell harvesting market has been segmented into product type, application, and end user.

### **Cell Harvesting Product Type Insights**

The cell harvesting market, on the basis of product type, has been segmented into manual cell harvesters and automated cell harvesters.

The manual cell harvesters segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the [automated cell harvesters](../../../reports/automated-cell-culture-market-767) segment is expected to be the fastest growing segment due to increased awareness and rise in the use of automated technologies in devices.

### **Cell Harvesting Application Insights**

The cell harvesting market, by application, has been segmented into biopharmaceutical application, [stem cell](../../../reports/stem-cell-therapy-market-6422) research, and others.

### **Cell Harvesting End User Insights**

The cell harvesting market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.

### **Cell Harvesting Regional Insights**

The cell harvesting market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Geographically, the Americas is anticipated to dominate the cell harvesting market owing to a well-developed healthcare sector and growing healthcare expenditure. For instance, according to the data published by the Committee for a Responsible Federal Budget in May 2018, the US spent about USD 3.5 trillion, or 18% of its Gross Domestic Product (GDP) on health expenditures, which accounted for more than twice the average among developed countries in  2017. Additionally, many companies in this region focus on the innovation of new treatment options, thus being a lucrative option for the growth of the cell harvesting market in this region.

Europe is expected to hold the second largest position in the cell harvesting market. The market growth in this region owes to the availability of funds for research. For instance, according to the data published by the National Institute of Health Funding (NIHR) in 2016, funding of EUR 928 million was announced for new NIHR Biomedical Research Centers (BRC) and NIHR Clinical Research Facilities (CRF) for five years starting from April 2017.

Asia-Pacific is anticipated to be the fastest growing region in the cell harvesting market due to the presence of a huge patient population and continuously developing economies.

On the other hand, the Middle East and Africa has the least share of the market. The majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.

**Cell Harvesting Market Key players**

## **Cell Harvesting Market Segmentation**

### **Cell Harvesting Product Type Outlook**

### **Cell Harvesting Application Outlook**

### **Cell Harvesting End User Outlook**

### **Cell Harvesting Region Outlook**

The report for Cell Harvesting Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry.

The report also gives a broad study of the different market segments and regions.

**Recent Development**

ADS-TEC is a producer and provider of high-quality, long-lasting Industrial IT systems, as well as high-performance battery systems and full storage solutions. ADS-in-house TEC's development is characterized by over 35 years of experience and professional skill in system development. ADS-TEC, a medium-sized company, employs around 240 people at two locations in Germany. The headquarters were transferred from Leinfelden-Echterdingen to a new facility in Nuertingen, near Stuttgart, in May 2014. The headquarters are supplemented by a manufacturing facility in Wilsdruff, near Dresden.

Argos Technologies delivers one-of-a-kind equipment and materials to help life scientists improve science. We stock the whole Argos Technologies product range, including the famous PolarSafe® products, for liquid handling, microbiology, cell biology, general laboratory, tabletop equipment, and cryogenic storage. Cryogenic storage racks and boxes, cryogenic vials and caps, upright freezer racks, labels, pipettes, pipette controllers, cell spreaders, mini centrifuges, centrifuge tubes, tube rotators, and other items are available in Agro technologies.

**Intended Audience**

### Cell Harvesting Market Industry Developments

- **Q2 2024: Avita Medical Receives FDA Approval for Expanded Use of RECELL System for Soft Tissue Repair** Avita Medical announced that the U.S. FDA approved an expanded indication for its RECELL Autologous Cell Harvesting System, allowing its use in soft tissue repair beyond burns. This regulatory milestone broadens the clinical application of the device in the U.S.
- **Q2 2024: Terumo BCT Launches Quantum Flex Cell Expansion System in Europe** Terumo Blood and Cell Technologies announced the commercial launch of its Quantum Flex Cell Expansion System in Europe, designed to automate and scale up cell therapy manufacturing, including cell harvesting processes.
- **Q1 2024: Lonza Opens New Cell and Gene Therapy Manufacturing Facility in Houston** Lonza inaugurated a new state-of-the-art cell and gene therapy manufacturing facility in Houston, Texas, expanding its capacity for cell harvesting and processing to support growing demand in regenerative medicine.
- **Q2 2024: Fujifilm Acquires Atara Biotherapeutics’ Cell Therapy Manufacturing Facility** Fujifilm announced the acquisition of Atara Biotherapeutics’ cell therapy manufacturing facility in California, strengthening its position in the cell harvesting and advanced therapy manufacturing sector.
- **Q1 2024: Sartorius Stedim Biotech Acquires CellGenix to Expand Cell Harvesting Reagents Portfolio** Sartorius Stedim Biotech completed the acquisition of CellGenix, a leading provider of cell harvesting reagents, to enhance its offering for cell and gene therapy manufacturing.
- **Q3 2024: Miltenyi Biotec Announces Strategic Partnership with Oxford Biomedica for Cell Harvesting Solutions** Miltenyi Biotec entered a strategic partnership with Oxford Biomedica to co-develop advanced cell harvesting and processing solutions for gene and cell therapy applications.
- **Q2 2024: Thermo Fisher Scientific Launches New Automated Cell Harvesting Platform** Thermo Fisher Scientific introduced a new automated cell harvesting platform aimed at improving efficiency and scalability in cell therapy manufacturing.
- **Q1 2025: BioNTech Announces $100 Million Investment in New Cell Therapy Manufacturing Site in Germany** BioNTech revealed plans to invest $100 million in a new manufacturing site in Germany dedicated to cell therapy and cell harvesting technologies, aiming to accelerate clinical and commercial production.
- **Q2 2025: Gilead Sciences Acquires Cell Harvesting Startup for $250 Million** Gilead Sciences acquired a cell harvesting technology startup to bolster its cell therapy pipeline and manufacturing capabilities.
- **Q1 2025: Cytiva Unveils Next-Generation Cell Harvesting System for Bioprocessing** Cytiva launched a next-generation cell harvesting system designed to improve yield and purity in large-scale bioprocessing applications.
- **Q3 2024: Beckman Coulter Life Sciences Expands Cell Harvesting Instrument Portfolio with New Automated System** Beckman Coulter Life Sciences announced the launch of a new automated cell harvesting instrument, expanding its portfolio for cell therapy and research applications.
- **Q2 2025: BlueRock Therapeutics Receives Health Canada Approval for Cell Harvesting Facility** BlueRock Therapeutics received regulatory approval from Health Canada to open a new cell harvesting and processing facility in Toronto, supporting its pipeline of regenerative medicine therapies.

## Market Drivers

### Growing Focus on Personalized Medicine

The shift towards personalized medicine is reshaping the Cell Harvesting Market. As healthcare moves away from one-size-fits-all approaches, the need for tailored therapies that cater to individual patient profiles becomes paramount. This trend necessitates the efficient harvesting of specific cell types, which can be utilized in personalized treatment plans. The market for personalized medicine is projected to grow significantly, with estimates suggesting it could reach USD 2 trillion by 2030. This growth is likely to drive demand for specialized cell harvesting techniques that can accommodate the unique requirements of personalized therapies. Thus, the Cell Harvesting Market is expected to expand in response to this evolving healthcare paradigm.

### Rising Demand for Cell-Based Therapies

The Cell Harvesting Market is experiencing a notable surge in demand for cell-based therapies, driven by advancements in regenerative medicine and personalized healthcare. As the prevalence of chronic diseases continues to rise, the need for effective treatment options becomes increasingly critical. According to recent data, the [cell therapy](https://www.marketresearchfuture.com/reports/cell-therapy-market-5066) market is projected to reach USD 20 billion by 2026, indicating a robust growth trajectory. This demand is further fueled by the increasing number of clinical trials focusing on cell therapies, which require efficient cell harvesting techniques. Consequently, the Cell Harvesting Market is poised to benefit from this trend, as healthcare providers seek innovative solutions to meet the growing therapeutic needs of patients.

### Increasing Investment in Stem Cell Research

Investment in stem cell research is a key driver for the Cell Harvesting Market. As researchers and institutions allocate more resources towards understanding stem cell biology and its applications, the demand for effective cell harvesting techniques intensifies. Recent reports indicate that funding for stem cell research has increased significantly, with government and private sectors investing billions annually. This influx of capital supports the development of advanced cell harvesting technologies, which are essential for isolating and purifying stem cells for therapeutic use. Consequently, the Cell Harvesting Market stands to gain from this trend, as enhanced research capabilities lead to more innovative applications and therapies in regenerative medicine.

### Technological Innovations in Cell Harvesting

Technological innovations play a pivotal role in shaping the Cell Harvesting Market. The introduction of automated cell harvesting systems and advanced bioprocessing technologies has significantly enhanced the efficiency and yield of cell recovery processes. For instance, the integration of microfluidics and automation in cell harvesting has streamlined workflows, reducing processing times and minimizing contamination risks. As a result, the market for automated cell harvesting solutions is expected to witness substantial growth, with estimates suggesting a compound annual growth rate of over 15% in the coming years. These innovations not only improve operational efficiency but also contribute to the overall quality of cell-based products, thereby driving the Cell Harvesting Market forward.

### Regulatory Support for Cell Therapy Development

Regulatory support is a crucial factor influencing the Cell Harvesting Market. Governments and regulatory bodies are increasingly recognizing the potential of cell therapies and are streamlining approval processes to facilitate their development. Initiatives aimed at expediting the review of cell-based products are becoming more common, which encourages investment and innovation within the sector. For instance, the introduction of fast-track designations for promising cell therapies has led to a more favorable environment for research and commercialization. This regulatory landscape not only enhances the viability of cell harvesting technologies but also fosters growth within the Cell Harvesting Market, as companies seek to align their products with evolving regulatory standards.

## Future Outlook

The Cell Harvesting Market is projected to grow at 8.79% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for cell therapies, and rising investments in regenerative medicine.

**New opportunities:**

- Development of automated cell harvesting systems for enhanced efficiency.
- Expansion into emerging markets with tailored cell harvesting solutions.
- Partnerships with biotech firms for innovative cell therapy applications.

By 2035, the Cell Harvesting Market is expected to achieve substantial growth, reflecting its critical role in biotechnology.

## Segment Insights

### By Product Type: Automated Cell Harvesters (Largest) vs. Manual Cell Harvesters (Fastest-Growing)

In the Cell Harvesting Market, the product type segment is chiefly dominated by Automated Cell Harvesters, which hold a substantial market share due to their efficiency and consistency in processing cell samples. Manual Cell Harvesters, while traditionally used, are experiencing a decline in market share as the healthcare and research sectors increasingly lean towards automation for streamlined operations. This trend exemplifies the shift towards more technologically advanced solutions in the industry.

Cell Harvesters: Automated (Dominant) vs. Manual (Emerging)

Automated Cell Harvesters represent the dominant force in the Cell Harvesting Market, being increasingly adopted due to their ability to enhance throughput and reduce error margins in cell processing. This type of harvester is particularly favored in large-scale laboratory environments, where precision and efficiency are paramount. In contrast, Manual Cell Harvesters are emerging in certain niche applications, especially in settings requiring more hands-on techniques or where cost considerations are critical. While they may not match the automation in speed, they remain essential for specific protocols where human expertise is indispensable.

### By Application: Biopharmaceutical Application (Largest) vs. Stem Cell Research (Fastest-Growing)

In the Cell Harvesting Market, the distribution of application segments showcases a clear dominance by the Biopharmaceutical Application, which plays a pivotal role in driving market expansion. This segment commands the majority share, emphasizing the reliance of pharmaceutical companies on effective cell harvesting techniques to produce therapeutics. Meanwhile, Stem Cell Research is emerging as a vital segment, steadily gaining traction due to its implications in [regenerative medicine](https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220) and innovative therapies. The Others category encompasses niche applications, contributing marginally in comparison to the leading segments.

Application Focus: Biopharmaceutical Application (Dominant) vs. Stem Cell Research (Emerging)

The Biopharmaceutical Application segment stands as the dominant player in the Cell Harvesting Market, capitalizing on advancements in bioprocessing and the urgent need for new therapies targeting complex diseases. Companies invest significantly in technologies that optimize cell retrieval processes, thereby underpinning the pharmaceutical industry's evolution. In contrast, Stem Cell Research, characterized as an emerging application, is rapidly gaining importance, fueled by breakthroughs in stem cell therapies and regenerative medicine. This segment benefits from increased funding and interest from both public and private sectors, providing a fertile ground for innovative applications in personalized medicine and health care solutions.

### By End User: Biotechnology Companies (Largest) vs. Pharmaceutical Companies (Fastest-Growing)

In the Cell Harvesting Market, Biotechnology Companies hold the largest share, driven by their focus on innovative therapies and the increasing demand for cellular treatments. On the other hand, Pharmaceutical Companies are witnessing significant growth rates as they increasingly adopt cell harvesting techniques in drug development and personalized medicine, capturing an expanding market share. Research Institutes and Others collectively form a smaller segment, leveraging their research capabilities but not matching the extensive needs of the leading sectors.

Biotechnology Companies (Dominant) vs. Pharmaceutical Companies (Emerging)

Biotechnology Companies are at the forefront of the Cell Harvesting Market, leveraging advanced technologies for cell therapy, regenerative medicine, and personalized treatment approaches. Their dominance is attributed to the increasing investments in R&D and a focus on developing novel therapeutics that require efficient cell extraction methods. In contrast, Pharmaceutical Companies are emerging rapidly, adopting cell harvesting techniques to enhance drug discovery processes, making them key players in the evolving landscape. Both sectors drive innovation and collaboration, influencing market trends and the adoption of new techniques.

## Regional Market Share Analysis

### North America : Innovation and Leadership Hub

North America is the largest market for cell harvesting, accounting for approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing investments in biotechnology, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in cell harvesting technologies.

The United States leads the market, with significant contributions from Canada. Key players such as Thermo Fisher Scientific, BD, and STEMCELL Technologies are headquartered here, fostering a competitive landscape. The presence of these industry leaders, along with ongoing collaborations between academia and industry, enhances innovation and drives market growth in North America.

### Europe : Emerging Market with Potential

Europe is the second-largest market for cell harvesting, holding around 30% of the global share. The region's growth is propelled by increasing investments in regenerative medicine and cell therapies, alongside supportive regulatory frameworks from the European Medicines Agency (EMA). Countries like Germany and the UK are at the forefront, driving demand for advanced cell harvesting solutions.

Germany is the leading country in this market, followed closely by the UK and France. The competitive landscape features key players such as Merck KGaA and Miltenyi Biotec, which are actively involved in research and development. The collaboration between public and private sectors enhances innovation, making Europe a promising region for future growth in cell harvesting technologies.

### Asia-Pacific : Rapidly Growing Market

Asia-Pacific is witnessing rapid growth in the cell harvesting market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing healthcare expenditures, a growing population, and rising awareness of advanced therapeutic options. Countries like China and India are emerging as key players, supported by government initiatives to boost biotechnology and healthcare sectors.

China is the largest market in the region, with significant contributions from India and Japan. The competitive landscape is characterized by the presence of both local and international players, including Lonza Group and Corning Incorporated. The increasing focus on research and development, along with favorable government policies, is expected to further enhance market growth in Asia-Pacific.

### Middle East and Africa : Untapped Potential and Growth

The Middle East and Africa region is gradually emerging in the cell harvesting market, holding about 5% of the global share. The growth is driven by increasing investments in healthcare infrastructure and a rising demand for advanced medical technologies. Countries like South Africa and the UAE are leading the way, supported by government initiatives aimed at improving healthcare services and biotechnology research.

South Africa is the largest market in this region, with the UAE following closely. The competitive landscape is still developing, with a mix of local and international players beginning to establish a presence. As the region continues to invest in healthcare and biotechnology, the cell harvesting market is expected to see significant growth in the coming years.

## Competitive Benchmarking

The Cell Harvesting Market is currently characterized by a dynamic competitive landscape, driven by advancements in biotechnology and increasing demand for cell-based therapies. Key players such as Thermo Fisher Scientific (US), Merck KGaA (DE), and BD (US) are strategically positioned to leverage their extensive product portfolios and innovative capabilities. Thermo Fisher Scientific (US) focuses on enhancing its cell harvesting technologies through continuous innovation, while Merck KGaA (DE) emphasizes strategic partnerships to expand its market reach. BD (US) is actively pursuing digital transformation initiatives to optimize its operational efficiency, thereby shaping a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The Cell Harvesting Market appears moderately fragmented, with a mix of established players and emerging companies. The collective influence of these key players is significant, as they drive innovation and set industry standards, thereby shaping the overall market structure.

In August 2025, Thermo Fisher Scientific (US) announced the launch of a new automated cell harvesting system designed to improve efficiency and reduce contamination risks in laboratory settings. This strategic move is likely to enhance their competitive edge by addressing critical pain points faced by researchers, thereby solidifying their position as a leader in the market.

In September 2025, Merck KGaA (DE) entered into a collaboration with a leading academic institution to develop next-generation cell harvesting technologies. This partnership is indicative of Merck's commitment to innovation and could potentially accelerate the development of novel solutions that meet the evolving needs of the biopharmaceutical industry.

In July 2025, BD (US) unveiled a new digital platform aimed at streamlining the cell harvesting process through real-time data analytics. This initiative not only enhances operational efficiency but also positions BD as a forward-thinking player in the market, likely attracting customers seeking advanced technological solutions.

As of October 2025, the Cell Harvesting Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

## Recent News & Developments

ADS-TEC is a producer and provider of high-quality, long-lasting Industrial IT systems, as well as high-performance battery systems and full storage solutions. ADS-in-house TEC's development is characterized by over 35 years of experience and professional skill in system development. ADS-TEC, a medium-sized company, employs around 240 people at two locations in Germany. The headquarters were transferred from Leinfelden-Echterdingen to a new facility in Nuertingen, near Stuttgart, in May 2014. The headquarters are supplemented by a manufacturing facility in Wilsdruff, near Dresden.

Argos Technologies delivers one-of-a-kind equipment and materials to help life scientists improve science. We stock the whole Argos Technologies product range, including the famous PolarSafe® products, for liquid handling, microbiology, cell biology, general laboratory, tabletop equipment, and cryogenic storage. Cryogenic storage racks and boxes, cryogenic vials and caps, upright freezer racks, labels, pipettes, pipette controllers, cell spreaders, mini centrifuges, centrifuge tubes, tube rotators, and other items are available in Agro technologies.

**Intended Audience**

### Cell Harvesting Market Industry Developments

- **Q2 2024: Avita Medical Receives FDA Approval for Expanded Use of RECELL System for [Soft Tissue Repair](https://www.marketresearchfuture.com/reports/soft-tissue-repair-market-7810)** Avita Medical announced that the U.S. FDA approved an expanded indication for its RECELL Autologous Cell Harvesting Market System, allowing its use in soft tissue repair beyond burns. This regulatory milestone broadens the clinical application of the device in the U.S.
- **Q2 2024: Terumo BCT Launches Quantum Flex Cell Expansion System in Europe** Terumo Blood and Cell Technologies announced the commercial launch of its Quantum Flex Cell Expansion System in Europe, designed to automate and scale up cell therapy manufacturing, including cell harvesting processes.
- **Q1 2024: Lonza Opens New Cell and [Gene Therapy](https://www.marketresearchfuture.com/reports/gene-therapy-market-8399) Manufacturing Facility in Houston** Lonza inaugurated a new state-of-the-art cell and gene therapy manufacturing facility in Houston, Texas, expanding its capacity for cell harvesting and processing to support growing demand in regenerative medicine.
- **Q2 2024: Fujifilm Acquires Atara Biotherapeutics’ Cell Therapy Manufacturing Facility** Fujifilm announced the acquisition of Atara Biotherapeutics’ cell therapy manufacturing facility in California, strengthening its position in the cell harvesting and advanced therapy manufacturing sector.
- **Q1 2024: Sartorius Stedim Biotech Acquires CellGenix to Expand Cell Harvesting Market Reagents Portfolio** Sartorius Stedim Biotech completed the acquisition of CellGenix, a leading provider of cell harvesting reagents, to enhance its offering for cell and gene therapy manufacturing.
- **Q3 2024: Miltenyi Biotec Announces Strategic Partnership with Oxford Biomedica for Cell Harvesting Market Solutions** Miltenyi Biotec entered a strategic partnership with Oxford Biomedica to co-develop advanced cell harvesting and processing solutions for gene and cell therapy applications.
- **Q2 2024: Thermo Fisher Scientific Launches New Automated Cell Harvesting Market Platform** Thermo Fisher Scientific introduced a new automated cell harvesting platform aimed at improving efficiency and scalability in cell therapy manufacturing.
- **Q1 2025: BioNTech Announces $100 Million Investment in New Cell Therapy Manufacturing Site in Germany** BioNTech revealed plans to invest $100 million in a new manufacturing site in Germany dedicated to cell therapy and cell harvesting technologies, aiming to accelerate clinical and commercial production.
- **Q2 2025: Gilead Sciences Acquires Cell Harvesting Market Startup for $250 Million** Gilead Sciences acquired a cell harvesting technology startup to bolster its cell therapy pipeline and manufacturing capabilities.
- **Q1 2025: Cytiva Unveils Next-Generation Cell Harvesting Market System for Bioprocessing** Cytiva launched a next-generation cell harvesting system designed to improve yield and purity in large-scale bioprocessing applications.
- **Q3 2024: Beckman Coulter Life Sciences Expands Cell Harvesting Market Instrument Portfolio with New Automated System** Beckman Coulter Life Sciences announced the launch of a new automated cell harvesting instrument, expanding its portfolio for cell therapy and research applications.
- **Q2 2025: BlueRock Therapeutics Receives Health Canada Approval for Cell Harvesting Market Facility** BlueRock Therapeutics received regulatory approval from Health Canada to open a new cell harvesting and processing facility in Toronto, supporting its pipeline of regenerative medicine therapies.

## Report Scope

| MARKET SIZE 2024 | 6.288(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.841(USD Billion) |
| MARKET SIZE 2035 | 15.89(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.79% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), Merck KGaA (DE), BD (US), Lonza Group (CH), Miltenyi Biotec (DE), STEMCELL Technologies (CA), Corning Incorporated (US), F. Hoffmann-La Roche Ltd (CH) |
| Segments Covered | Product Type, Applications |
| Key Market Opportunities | Advancements in automated cell harvesting technologies enhance efficiency and scalability in the Cell Harvesting Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the cell harvesting market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Cell Harvesting Market as of 2024?**
A: The Cell Harvesting Market was valued at 6.288 USD Billion in 2024.

**Q: What is the projected market size for the Cell Harvesting Market by 2035?**
A: The market is projected to reach 15.89 USD Billion by 2035.

**Q: What is the expected CAGR for the Cell Harvesting Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Cell Harvesting Market during 2025 - 2035 is 8.79%.

**Q: Which product type segment is anticipated to grow the most in the Cell Harvesting Market?**
A: The Automated Cell Harvesters segment is expected to grow from 3.788 USD Billion to 10.39 USD Billion by 2035.

**Q: How does the Biopharmaceutical Application segment perform in the Cell Harvesting Market?**
A: The Biopharmaceutical Application segment is projected to increase from 2.5 USD Billion to 6.0 USD Billion by 2035.

**Q: What are the key players in the Cell Harvesting Market?**
A: Key players include Thermo Fisher Scientific, Merck KGaA, BD, Lonza Group, and Miltenyi Biotec.

**Q: What is the expected growth for the Stem Cell Research application in the Cell Harvesting Market?**
A: The Stem Cell Research application is likely to grow from 2.0 USD Billion to 5.0 USD Billion by 2035.

**Q: Which end user segment is projected to dominate the Cell Harvesting Market?**
A: Pharmaceutical Companies are expected to dominate, growing from 2.5 USD Billion to 6.0 USD Billion by 2035.

**Q: What is the growth outlook for Research Institutes in the Cell Harvesting Market?**
A: Research Institutes are projected to grow from 1.0 USD Billion to 2.5 USD Billion by 2035.

**Q: How does the Others segment perform across different applications in the Cell Harvesting Market?**
A: The Others segment is expected to grow from 1.788 USD Billion to 4.89 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/cell-harvesting-market-6801*